Compare LXRX & ADAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LXRX | ADAM |
|---|---|---|
| Founded | 1995 | 2003 |
| Country | United States | United States |
| Employees | N/A | 221 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 703.3M | 655.0M |
| IPO Year | 2000 | N/A |
| Metric | LXRX | ADAM |
|---|---|---|
| Price | $2.32 | $8.99 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $4.15 | ★ $9.17 |
| AVG Volume (30 Days) | ★ 2.9M | 846.5K |
| Earning Date | 05-01-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 11.87% |
| EPS Growth | ★ 77.78 | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $49,803,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.08 |
| P/E Ratio | ★ N/A | $41.51 |
| Revenue Growth | ★ 60.24 | N/A |
| 52 Week Low | $0.52 | $6.45 |
| 52 Week High | $2.53 | $9.32 |
| Indicator | LXRX | ADAM |
|---|---|---|
| Relative Strength Index (RSI) | 70.85 | 64.57 |
| Support Level | $1.44 | $6.86 |
| Resistance Level | N/A | $9.32 |
| Average True Range (ATR) | 0.16 | 0.32 |
| MACD | 0.08 | 0.04 |
| Stochastic Oscillator | 80.20 | 78.55 |
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Adamas Trust Inc is an internally-managed REIT for U.S. federal income tax purposes, in the business of acquiring, investing in, financing, and managing mainly mortgage-related single-family and multi-family residential assets. Its objective is to deliver long-term stable distributions to its stockholders over changing economic conditions through a combination of net interest spread and capital gains from a diversified investment portfolio. The company's investment portfolio includes credit-sensitive single-family and multi-family assets.